Bibliographic Details
| Title: |
Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action. |
| Authors: |
Chernyshova, Irina1 (AUTHOR) chernyshova0305@gmail.com, Vasil'eva, Inna1 (AUTHOR) iva@niboch.nsc.ru, Moor, Nina1 (AUTHOR) moor@niboch.nsc.ru, Ivanisenko, Nikita2,3 (AUTHOR) ivanisenko@bionet.nsc.ru, Kutuzov, Mikhail1 (AUTHOR) kutuzov.mm@mail.ru, Abramova, Tatyana1 (AUTHOR) abramova@niboch.nsc.ru, Zakharenko, Alexandra1 (AUTHOR) sashaz@niboch.nsc.ru, Lavrik, Olga1 (AUTHOR) lavrik@niboch.nsc.ru |
| Source: |
International Journal of Molecular Sciences. Dec2024, Vol. 25 Issue 23, p12526. 18p. |
| Subject Terms: |
*DNA repair, *DNA damage, *MOLECULAR docking, *NUCLEOSIDES, *CYTOTOXINS, *POLY ADP ribose |
| Abstract: |
Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2) play a key role in DNA repair. As major sensors of DNA damage, they are activated to produce poly(ADP-ribose). PARP1/PARP2 inhibitors have emerged as effective drugs for the treatment of cancers with BRCA deficiencies. Here, we explored aminomethylmorpholino and aminomethylmorpholino glycine nucleosides as inhibitors of PARP1 and PARP2, using different enzymatic assays. The compounds bearing thymine or 5-Br(I)-uracil bases displayed the highest inhibition potency, with all of them being more selective toward PARP1. Interaction of the inhibitors with the NAD+ binding cavity of PARP1 (PARP2) suggested by the mixed-type inhibition was demonstrated by molecular docking and the RoseTTAFold All-Atom AI-model. The best PARP1 inhibitors characterized by the inhibition constants in the range of 12–15 µM potentiate the cytotoxicity of hydrogen peroxide by displaying strong synergism. The inhibitors revealed no impact on PARP1/PARP2 affinity for DNA, while they reduced the dissociation rate of the enzyme–DNA complex upon the autopoly(ADP-ribosyl)ation reaction, thus providing evidence that their mechanism of action for PARP trapping is due primarily to catalytic inhibition. The most active compounds were shown to retain selectivity toward PARP1, despite the reduced inhibition potency in the presence of histone PARylation factor 1 (HPF1) capable of regulating PARP1/PARP2 catalytic activity and ADP-ribosylation reaction specificity. The inhibitors obtained seem to be promising for further research as potential drugs. [ABSTRACT FROM AUTHOR] |
|
Copyright of International Journal of Molecular Sciences is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Academic Search Complete |
|
Full text is not displayed to guests. |
Login for full access.
|
